raw sugar hand sanitizer- peppermint and sea salt.- alcohol gel
bolero home decor, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antimicrobial. - hand sanitizing to reduce bacteria on the skin that could cause disease. - recommended for repeated use.
raw sugar hand sanitizer- coconut and lemon verbena- alcohol gel
bolero home decor, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antimicrobial. - hand sanitizing to reduce bacteria on the skin that could cause disease. - recommended for repeated use.
raw sugar hand sanitizer eucalyptus and tea tree- alcohol gel
bolero home decor, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - hand sanitizing to reduce bacteria on the skin that could cause disease - recommended for repeated use
raw sugar hand sanitizer coconut and lemon verbena- alcohol gel
bolero home decor, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - hand sanitizing to reduce bacteria on the skin that could cause disease - recommended for repeated use
raw sugar hand sanitizer peppermint and sea salt- alcohol gel
bolero home decor, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - hand sanitizing to reduce bacteria on the skin that could cause disease - recommended for repeated use
raw sugar hand sanitizer watermelon and aloe vera- alcohol gel
bolero home decor, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - hand sanitizing to reduce bacteria on the skin that could cause disease - recommended for repeated use
afinitor 5 mg
novartis israel ltd - everolimus - tablets - everolimus 5 mg - everolimus - everolimus - - for the treatment of patients with sega associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection.the effectiveness of afinitor is based on an analysis of change in sega volume. clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated.- treatment of progressive neuroendocrine tumors of pancreatic origin (pnet) in patients with unresectable, locally advanced or metastatic disease.the safety and effectiveness of afinitor® in the treatment of patients with carcinoid tumors have not been established.- for the treatment of hormone receptor – positive, her2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.- afinitor ® is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (tsc), not requiring immediate surgery. the effectiveness of afinitor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. further follow-up of patients is required to determine long-term outcomes.- afinitor ® is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with vegf-targeted therapy.- treatment of unresectable, locally advanced or metastatic, well-differentiated (grade 1 or grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease
afinitor 10 mg
novartis israel ltd - everolimus - tablets - everolimus 10 mg - everolimus - everolimus - - for the treatment of patients with sega associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection.the effectiveness of afinitor is based on an analysis of change in sega volume. clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated.- treatment of progressive neuroendocrine tumors of pancreatic origin (pnet) in patients with unresectable, locally advanced or metastatic disease.the safety and effectiveness of afinitor® in the treatment of patients with carcinoid tumors have not been established.- for the treatment of hormone receptor – positive, her2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.- afinitor ® is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (tsc), not requiring immediate surgery. the effectiveness of afinitor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. further follow-up of patients is required to determine long-term outcomes.- afinitor ® is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with vegf-targeted therapy.- treatment of unresectable, locally advanced or metastatic, well-differentiated (grade 1 or grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease
afinitor 2.5 mg
novartis israel ltd - everolimus - tablets - everolimus 2.5 mg - everolimus - everolimus - - for the treatment of patients with sega associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection.the effectiveness of afinitor is based on an analysis of change in sega volume. clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated.- treatment of progressive neuroendocrine tumors of pancreatic origin (pnet) in patients with unresectable, locally advanced or metastatic disease.the safety and effectiveness of afinitor® in the treatment of patients with carcinoid tumors have not been established.- for the treatment of hormone receptor – positive, her2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.- afinitor ® is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (tsc), not requiring immediate surgery. the effectiveness of afinitor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. further follow-up of patients is required to determine long-term outcomes.- afinitor ® is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with vegf-targeted therapy.- treatment of unresectable, locally advanced or metastatic, well-differentiated (grade 1 or grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease
phonak bolero q hearing aids (bte wireless)
sonova singapore pte. ltd. - ear, nose & throat - the intended use of hearing aids is to amplify and transmit sound to the ears and hereby compensate for impaired hearing.